Clinical Trial Update: NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain [Phase 3]

View source ↗

Summary

Phase III trial update for NORSPAN transdermal fentanyl patches in non-cancer pain has completed the study in patients with pain associated with intervertebral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intervertebral Disc Disease with Myelopathy
• Pain

Drugs mentioned

• Norspan (buprenorphine)

Snippet

Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd | Conditions: Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation) | Phase 3 | Status: COMPLETED